Therapy Areas: Infectious Diseases
Charles River and Medigen collaborate on next-generation enterovirus vaccine development
20 August 2026 - Pharmaceutical research services provider Charles River Laboratories International Inc (NYSE:CRL) and Medigen Vaccine Biologics Corp (MVC), a developer of vaccines for infectious dise...
Amplitude Therapeutics and Lilly collaborate on trans-amplifying RNA vaccine development for infectious diseases
20 August 2026 - Amplitude Therapeutics, a biotechnology company developing trans-amplifying RNA (taRNA) medicines and vaccines, announced on Wednesday a strategic research collaboration and licensing...
Roche expands cyclospora testing portfolio to support US public health response
6 August 2026 - Swiss biotechnology company Roche (SIX: RO, ROG; OTCQX: RHHBY), in collaboration with subsidiary TIB MOLBIOL, announced on Thursday the launch of two new real-time PCR tests to help la...
Decoy Therapeutics expands antiviral platform into Ebola and filovirus research
27 July 2026 - Biotechnology company Decoy Therapeutics Inc (Nasdaq: DCOY) reported on Monday that a D-MAV antiviral candidate demonstrated in vitro activity against wild-type Ebola Zaire virus, expan...
ABL Diagnostics selected to acquire TEXCELL operations
23 July 2026 - ABL Diagnostics (Euronext Paris:ABLD), a provider of molecular biology tests, announced on Thursday that it has been selected by the Évry Commercial Court to acquire the assets a...
Nona Biosciences agrees research collaboration with Medical University of Vienna to advance fully human antibody development for infectious diseases
23 July 2026 - Global biotechnology company Nona Biosciences, a wholly owned subsidiary of HBM Holding Limited (HKEX:02142), announced on Wednesday a research collaboration with the Medical University...